Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 247

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Assessment of Atrioventricular Junction Ablation and DDDR Mode-Switching Pacemaker Versus Pharmacological Treatment in Patients With Severely Symptomatic Paroxysmal Atrial Fibrillation: A Randomized Controlled Study

Brignole, Michele, Gianfranchi, Lorella, Menozzi, Carlo, Alboni, Paolo, Musso, Giacomo, Bongiorni, Maria Grazia, Gasparini, Maurizio, Raviele, Antonio, Lolli, Gino, Paparella, Nelly, Acquarone, Simonetta·1997·Circulation

Abstract

Background The purpose of the study was to evaluate the effect of AV junction ablation and pacemaker implantation on quality of life and specific symptoms in patients with paroxysmal atrial fibrillation (AF) not controlled by drugs. Methods and Results We performed a multicenter, randomized, 6-month evaluation of the clinical effects of AV junction ablation and DDDR mode-switching pacemaker (Abl+Pm) versus pharmacological treatment in 43 patients with intolerable, recurrent paroxysmal AF of three or more episodes in the previous 6 months not controlled with three or more antiarrhythmic drugs. Before completion of the study, 3 patients in the drug group withdrew because of the severity of their symptoms and 1 patient assigned to the Abl+Pm group in whom the ablation procedure failed. At the end of the 6 months, the 21 patients of the Abl+Pm group who completed the study showed, in comparison with the 18 of the drug group, lower scores in the Living with Heart Failure Questionnaire (−51%, P =.0006), palpitations (−71%, P =.0000), effort dyspnea (−36%, P =.04), exercise intolerance score (−46%, P =.001), and easy fatigue (−51%, P =.02). The scores for rest dyspnea, chest discomfort, and NYHA functional classification were also lower (−56%, −50%, and −17%, respectively) in the Abl+Pm group, although not significantly. At the end of the study, palpitations were no longer present in 81% of the Abl+Pm group and in 11% of the drug group ( P =.0000). AF was documented in 31 of 122 visits (25%) in the Abl+Pm group and in 9 of 107 examinations (8%) in the drug group ( P =.0005); chronic AF developed in 5 (24%) and 0 (0%) in the two groups, respectively ( P =.04). Conclusions In patients with paroxysmal AF not controlled by pharmacological therapy, Abl+Pm treatment is highly effective and superior to drug therapy in controlling symptoms and improving quality of life. The discontinuation of drug therapy exposes patients to further recurrences of paroxysmal AF and the risk of developing permanent AF.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/01.cir.96.8.2617

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 247

Metadata

Authors
Brignole, M., Gianfranchi, L., Menozzi, C., Alboni, P., Musso, G., Bongiorni, M. G., Gasparini, M., Raviele, A., Lolli, G., Paparella, N., & Acquarone, S.
Venue
Circulation
Published
1997-10-21
Volume
96
Issue
8
Pages
2617-2624
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W2075135210
Cited by
247
References
2
FWCI
12.32
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Assessment of Atrioventricular Junction Ablation and DDDR Mode-Switching Pacemaker Versus Pharmacological Treatment in Patients With Severely Symptomatic Paroxysmal Atrial Fibrillation: A Randomized Controlled Study. https://app.cochat.ai/papers/10.1161/01.cir.96.8.2617
The paper
Brignole, M., Gianfranchi, L., Menozzi, C., Alboni, P., Musso, G., Bongiorni, M. G., Gasparini, M., Raviele, A., Lolli, G., Paparella, N., & Acquarone, S. (1997). Assessment of Atrioventricular Junction Ablation and DDDR Mode-Switching Pacemaker Versus Pharmacological Treatment in Patients With Severely Symptomatic Paroxysmal Atrial Fibrillation: A Randomized Controlled Study. Circulation. https://doi.org/10.1161/01.cir.96.8.2617

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.